SEC Form 4 · accession 0001628280-16-012775
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bollag
Officer — Sr. VP, Reg. Affairs & Quality
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2016 | M | 3,750 | $1.30 | A | 154,838 | D | |
| Common Stock | Mar 15, 2016 | D | 22,814 | $6.1808 | D | 132,024 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $1.30 | Mar 15, 2016 | M | 3,750 | D | — | Mar 10, 2009 | Common Stock | 3,750 | 0 | D |
Explanation of responses
- F1Shares were acquired from exercise of an outstanding stock option
- F2Shares were sold pursuant to a Rule 10b5-1 trading plan
- F3Options vested 25% per year on each March 10, 2010, 2011, 2012 and 2013.